Rabourn Amy Zaremba Ocuphire Pharma, Inc. (OCUP) insider trading activity

OCUP Quotes by TradingView

Rabourn Amy Zaremba is Head of Fin. Quality Assurance of Ocuphire Pharma, Inc.. Currently has a direct ownership of 110,018 shares of OCUP, which is worth approximately $107,817. The most recent transaction as insider was on Jan 10, 2026, when has been sold 3,950 shares (Common Stock) at a price of $1.93 per share, resulting in proceeds of $7,623. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 110K
3.47% 3M change
33.1% 12M change
Total Value Held $107,817

Rabourn Amy Zaremba Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 10 2026
SELL
Payment of exercise price or tax liability
$7,623 $1.93 p/Share
3,950 Reduced 3.47%
110,018 Common Stock
Mar 13 2025
BUY
Grant, award, or other acquisition
-
39,500 Added 25.74%
113,968 Common Stock
Feb 04 2025
SELL
Payment of exercise price or tax liability
$9,336 $1.14 p/Share
8,190 Reduced 9.91%
74,468 Common Stock
Jan 18 2024
BUY
Grant, award, or other acquisition
-
40,000 Added 32.61%
82,658 Common Stock
Jan 10 2024
SELL
Payment of exercise price or tax liability
$12,916 $3.27 p/Share
3,950 Reduced 8.47%
42,658 Common Stock
Jan 10 2023
BUY
Grant, award, or other acquisition
-
46,608 Added 50.0%
46,608 Common Stock
RAZ

Rabourn Amy Zaremba

Head of Fin. Quality Assurance
Farmington Hills, MI

Track Institutional and Insider Activities on OCUP

Follow Ocuphire Pharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OCUP shares.

Notify only if

Insider Trading

Get notified when an Ocuphire Pharma, Inc. insider buys or sells OCUP shares.

Notify only if

News

Receive news related to Ocuphire Pharma, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on OCUP